TRDA – entrada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Entrada Therapeutics (TRDA) had its price target raised by Oppenheimer Holdings, Inc. from $21.00 to $23.00. They now have an "outperform" rating on the stock.
Entrada Therapeutics (TRDA) is now covered by Cantor Fitzgerald. They set an "overweight" rating on the stock.
Entrada Therapeutics (TRDA) was downgraded by Wall Street Zen from "h
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Entrada Therapeutics (TRDA) was upgraded by Wall Street Zen from "sel
Form 4 Entrada Therapeutics, For: Apr 01 Filed by: WENTWORTH KORY JAMES
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Form 4 Entrada Therapeutics, For: Mar 09 Filed by: Dowden Nathan J
Form 4 Entrada Therapeutics, For: Mar 09 Filed by: WENTWORTH KORY JAMES
Form 144 Entrada Therapeutics, Filed by: WENTWORTH KORY JAMES
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.